Loading clinical trials...
Loading clinical trials...
A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients With Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (BMT CTN 1501)
Conditions
Interventions
Sirolimus
Prednisone
Locations
21
United States
City of Hope National Medical Center
Duarte, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
University of Florida College of Medicine (Shands)
Gainesville, Florida, United States
H. Lee Moffitt Cancer Center
Tampa, Florida, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Emory University
Atlanta, Georgia, United States
Start Date
October 1, 2016
Primary Completion Date
August 17, 2018
Completion Date
February 19, 2019
Last Updated
November 1, 2021
NCT02611180
NCT03701698
NCT04645667
NCT01530256
Lead Sponsor
Medical College of Wisconsin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions